343 related articles for article (PubMed ID: 15013387)
1. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Ikeda R; Maeda T
Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
[TBL] [Abstract][Full Text] [Related]
2. Application of proton nuclear magnetic resonance spectroscopy to the study of Cryptococcus and cryptococcosis.
Sorrell TC; Wright LC; Malik R; Himmelreich U
FEMS Yeast Res; 2006 Jun; 6(4):558-66. PubMed ID: 16696651
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
Rodríguez Sánchez H; Pupo Antúnez M; Ilnait MT; Otero A; Martínez Machín G
Rev Cubana Med Trop; 2005; 57(2):162-4. PubMed ID: 17966590
[TBL] [Abstract][Full Text] [Related]
4. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
[TBL] [Abstract][Full Text] [Related]
5. [The structure of extracellular heteroglycans in various Cryptococcus species].
Vitovskaia G; Samarkina GM; Anan'eva EP; Shashkov AS; Goncharov AIu
Bioorg Khim; 1988 Oct; 14(10):1405-12. PubMed ID: 3233098
[TBL] [Abstract][Full Text] [Related]
6. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.
Cherniak R; Jones RG; Reiss E
Carbohydr Res; 1988 Jan; 172(1):113-38. PubMed ID: 3280130
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
[TBL] [Abstract][Full Text] [Related]
8. The structure of a
Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2315733121. PubMed ID: 38330012
[No Abstract] [Full Text] [Related]
9. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
[TBL] [Abstract][Full Text] [Related]
10. [Cryptococcus neoformans, var. neoformans, Cryptococcus neoformans var. gattii, causative agents of cryptococcosis].
Swinne D; Lumbila M
Bull Mem Acad R Med Belg; 1987; 142(2-3):238-48. PubMed ID: 3311260
[No Abstract] [Full Text] [Related]
11. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages.
Grinsell M; Weinhold LC; Cutler JE; Han Y; Kozel TR
J Infect Dis; 2001 Aug; 184(4):479-87. PubMed ID: 11471106
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans.
Ikeda R; Saito F; Matsuo M; Kurokawa K; Sekimizu K; Yamaguchi M; Kawamoto S
J Bacteriol; 2007 Jul; 189(13):4815-26. PubMed ID: 17483230
[TBL] [Abstract][Full Text] [Related]
13. Isolation of Cryptococcus species including C. neoformans from cloaca of pigeons.
Rosario I; Hermoso de Mendoza M; Déniz S; Soro G; Alamo I; Acosta B
Mycoses; 2005 Nov; 48(6):421-4. PubMed ID: 16262879
[TBL] [Abstract][Full Text] [Related]
14. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.
Villena SN; Pinheiro RO; Pinheiro CS; Nunes MP; Takiya CM; DosReis GA; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
Cell Microbiol; 2008 Jun; 10(6):1274-85. PubMed ID: 18284419
[TBL] [Abstract][Full Text] [Related]
15. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
[TBL] [Abstract][Full Text] [Related]
16. Antigenic structure of Cryptococcus neoformans capsular polysaccharides.
Kozel TR
Immunol Ser; 1989; 47():63-86. PubMed ID: 2484982
[No Abstract] [Full Text] [Related]
17. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
[TBL] [Abstract][Full Text] [Related]
18. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.
Ikeda R; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1985; 29(10):981-91. PubMed ID: 3908888
[TBL] [Abstract][Full Text] [Related]
19. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
Parra C; González JM; Castañeda E; Fiorentino S
Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
[TBL] [Abstract][Full Text] [Related]
20. [Detection of capsular polysaccharide antigen of Cryptococcus neoformans in patients with AIDS and neurocryptococcosis in São Paulo, Brazil].
Calvo B; Fischman O; Castelo Filho A; Reis Filho J; Del Bianco R; Barbosa RM; Zaror L
Rev Inst Med Trop Sao Paulo; 1991; 33(6):485-90. PubMed ID: 1844979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
